Compare BVS & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BVS | NPFD |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 459.8M |
| IPO Year | 2021 | N/A |
| Metric | BVS | NPFD |
|---|---|---|
| Price | $7.40 | $19.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 277.3K | 64.7K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.28% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $563,829,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.11 | N/A |
| P/E Ratio | $48.57 | ★ N/A |
| Revenue Growth | ★ 1.58 | N/A |
| 52 Week Low | $5.81 | $14.50 |
| 52 Week High | $11.25 | $18.07 |
| Indicator | BVS | NPFD |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 37.29 |
| Support Level | $7.26 | $19.00 |
| Resistance Level | $7.71 | $19.15 |
| Average True Range (ATR) | 0.26 | 0.14 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 44.75 | 17.57 |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.